Folixapure NDC 59088-163

NDC codes

FDA NDC Directory

Product NDC (as listed)59088-163Labeler and product segments. Claims need a package NDC.

Product NDC at billing width59088-0163Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
59088-163-54	59088016354	30 TABLET in 1 BOTTLE, PLASTIC (59088-163-54)Marketed from Jul 10, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Folixapure
Generic name (nonproprietary): folic acid, vitamin d3
Active ingredients: Folic acid — 1 mg/1Vitamin d — 125 ug/1
Dosage form: Tablet
Route: Oral
Labeler: PureTek Corporation
Product type: Prescription drug
Marketing category: Unapproved drug (other)
Marketing start: Jul 10, 2020
Listing expires: Dec 31, 2026
Other FDA classes: Vitamin D (Chemical structure)
Identifiers: Product ID 59088-163_f2048d71-679b-98f8-e053-2995a90a533aSPL ID f2048d71-679b-98f8-e053-2995a90a533aSPL set ID aa1daf3a-9673-6996-e053-2a95a90a5f87RxCUI 1720258UNII 935E97BOY8, 9VU1KI44GPUPC 0359088163542
Pharmacologic class: Vitamin D

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N459088016354 followed by a unit qualifier and the quantity

Package 59088-0163-54. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 11, 2023.

Indications (excerpt from the label)

INDICATIONS AND DOSAGE Folixapure™ is indicated for dietary management of patients with unique nutritional needs requiring increased folate levels and Vitamin D supplementation. Folixapure™ can be taken by women of childbearing age, pregnant women, and lactating and nonlactating mothers.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)